pharmaphorum

NOVEMBER 28, 2021

The three-year phase 2 trial will be carried out by researchers at Leeds University led by professor of clinical oncology and neuro-oncology Susan Short, and see if adding Sativex (nabiximols) to standard chemotherapy for recurrent glioblastoma can extend survival. Jazz acquired rights to Sativex when it completed its $7.2

Chemotherapy

pharmaphorum

NOVEMBER 29, 2022

Those immunologically cold gastrointestinal tumours present a real clinical challenge, with a standard of care heavily relying on chemotherapy approaches. Prior to his position at NIT, Dr Yang was Genexine’s Head of Research Institute and Business Division from 2007 to 2014 and has served as a BOD member of Genexine.

Immunization

The Thyroid Pharmacist

SEPTEMBER 20, 2024

Plecanatide : This is one of the newest medications for IBS-C that has been approved by the FDA. Tenapanor : Tenapanor was approved by the FDA in September of 2019 for IBS-C. Tegaserod : This medication was approved for IBS-C in 2002, but removed from the market in 2007 due to an increased risk of cardiovascular events.

Health and Personal Care Stores

PharmaShots

MARCH 29, 2023

Lupin has earned the US FDA approval for the generic version of Banzel as Rufinamide Oral Suspension. It is the only drug in its class of chemotherapy and is developed from the natural substance found in a sea sponge. The exact mechanism of action is uncertain. Glenmark has also released its generic drug version in the US market.

FDA

The Checkup by Singlecare

FEBRUARY 21, 2023

An extensive 2007 study that pooled data from three independent clinical trials on more than 1,100 patients concluded that duloxetine was an effective treatment for anxiety. Cymbalta dosage for anxiety According to the FDA , the recommended dosage of Cymbalta for adults younger than 65 years old with anxiety is 60 mg, taken once daily.

Dosage